Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Two strengths of sertraline among further 13 April price concessions

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 13 items for April 2020 prescriptions.

An initial 11 price concessions were announced on April 15. A further 20 items were added to the list on April 17, and a another 18 on April 22.

Drug
Strength
Form
Price
Aciclovir
400mg
tablets (56)
£3.32
Co-codamol
15mg/500mg
tablets (100)
£3.99
Frovatriptan
2.5mg
tablets (6)
£11.91
Ibuprofen
400mg
tablets (24)
£2.00
Ibuprofen
400mg
tablets (84)
£6.99
Mometasone
50 micrograms/dose
nasal spray (140 doses)
£5.95
Paracetamol
250mg/5ml
oral suspension sugar free (200ml)
£4.27
Sertraline
100mg
tablets (28)
£14.07
Sertraline
50mg
tablets (28)
£8.95
Sulpiride
200mg
tablets (30)
£6.86
Tacrolimus
0.1%
ointment (30g)
£25.92
Valaciclovir
500mg
tablets (10)
£20.59
Tamoxifen
20mg
tablets (30)
£5.50

Do these prices reflect what you've paid so far this month?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006467

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel